-
1 Comment
Zhejiang Int'l Group Co.,Ltd is currently in a long term downtrend where the price is trading 17.5% below its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.1.
Zhejiang Int'l Group Co.,Ltd's total revenue rose by 1.8% to $7B since the same quarter in the previous year.
Its net income has increased by 34.9% to $35M since the same quarter in the previous year.
Finally, its free cash flow fell by 13.5% to $-352M since the same quarter in the previous year.
Based on the above factors, Zhejiang Int'l Group Co.,Ltd gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE0000008D9 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Dividend Yield | 3.5% |
|---|---|
| Target Price | 35.75 |
| Beta | 0.61 |
| Market Cap | 6B |
| PE Ratio | 11.13 |
Zhejiang Int'l Group Co.,Ltd. engages in the wholesale and retail of pharmaceuticals and medical devices. The company was founded in 1950 and is based in Hangzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000411.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
